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Abstract 
Background: The aim of the present study was to explore the relationships between Obstructive Sleep Apnea (OSA), daytime 
sleepiness, nasal geometry, nasal airflow, and patient- reported sino-nasal symptoms.
Methodology: Six hundred and fifty-one consecutive patients with suspected sleep related breathing disorder (SRBD) were 
included in the study. OSA was assessed by the Apnea-Hypopnea Index (AHI) and Oxygen Desaturation Index (ODI). Nasal airflow 
was measured with Peak Nasal Inspiratory Flow (PNIF). Nasal geometry was measured with Acoustic Rhinometry (AR). Sino-nasal 
symptoms were graded on Visual Analogue Scales (VAS) as nose-VAS scores. Daytime sleepiness was quantified by the Epworth 
Sleepiness Scale (EpSS).
Results: There were no general relationship between EpSS scores and nasal airflow, nasal geometry, AHI or ODI scores. When the 
previously shown nose-VAS associations to EpSS were studied by the AHI score levels, the associations were present primarily 
among patients with AHI below 15.  An exception was the nose-VAS question about “general health” where the association was 
present for all patients. If the patients were divided by AHI=15 as a cut-off point, an EpSS-unique association to reduced “general 
health” was found only among the patients with high AHI scores. The Minimal Cross Sectional Area in the posterior part of the 
nose (MCA2) scored inversely to EpSS among all patients, and was in particular present among patients with AHI below 15.
Conclusions: OSA seems largely to be a separate entity from nose function, nasal geometry and nose symptoms.
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Introduction
Obstructive Sleep Apnea (OSA) is a widespread sleep disorder. 
The prevalence may depend on associated pathologies, Body 
Mass Index (BMI), age and gender (1). OSA is characterized by 
partial or complete airway collapse during sleep with incre-
ased upper airway resistance and risk of hypopnea or apnea as 
consequences (2). Reported symptoms and signs of OSA include 
loud snoring, restless sleep, shallow breathing with apnea, and 
excessive daytime sleepiness. Hrubos-Strøm et al. found in 2011 
that 24.3% of middle-aged Norwegians were at high risk of OSA, 
and that the prevalence of the disorder in the overall population 
were 16% as defined by apnea-hypopnea index (AHI) of 5 or 
above. The corresponding figure for AHI of 15 or above was 8% 
(3). Numerous studies have shown that if untreated, OSA may 
have diverse and serious consequences.  It is associated with 
increased risk for cardiovascular morbidity and mortality, stroke, 
type 2 diabetes, neurological and psychiatric deficits as well as 
automobile accidents (4,5).
The nose plays an important role in sleep. For most healthy 
subjects, it is the preferred route of sleep breathing, probably 
because nasal resistance is considerably lower than oral resis-
tance during sleep (6). Reduced nasal patency may have major 
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negative impact on sleep. Serrano et al. described a two-fold risk 
of disturbed sleep in patients with nasal polyposis compared 
to controls (7) . Allergic rhinitis affects sleep (8). It has also been 
described that patients with chronic rhinosinusitis (CRS), fre-
quently involving nasal obstruction, have  reduced sleep quality, 
increased risk of waking up unrested, and increased daytime 
sleepiness (9). 
As nasal patency seems to be a determining factor for sleep 
quality, the physiologic, pathophysiologic and therapeutically 
relationship between the two should be expected to be a sub-
ject of major scientific attention. So far, this does not appear to 
be the case. The existing data on relationships and associations 
are limited and inconclusive. Thus, we still miss investigations 
that enable scientifically based decisions about if or how to 
involve the nose in order to improve sleep and SRBD. 
In the present investigation we focused on the relationship 
between the nose parameters patients’ self-reported sino-nasal 
symptoms, nasal airflow, and nasal geometry and the sleep 




The inclusion criteria in this study was suspicion of SRBD.  SRBD 
includes several chronic disorders characterized by excessive 
daytime sleepiness and witnessed apneas and / or hypopneas 
and excessive nighttime snoring (10). Six hundred and fifty one 
(651) patients referred to the Dept. of Otolaryngology, Head and 
Neck Surgery, Sørlandet Hospital, Kristiansand, Norway were 
consecutively recruited after informed consent. There were 458 
males and 193 females. The mean±SD age was 46.5±12.0 years 
(range: 19-81 years). Furthermore, 14.8 % had an apnea-hypop-
nea index (AHI) below 5, 85.2 % above. The patients responded 
to a questionnaire about co-morbidity with answering alterna-
tives YES or NO. The patients also reported number pack-years 
of smoking, and level of alcohol consumption. Exclusion criteria 
were previous surgery in the nose and pharynx, systemic inflam-
matory disorders like Wegner and sarcoidosis, drug induced 
rhinitis, current or previous malignancies in the upper airways. 
Topical nasal steroids and antihistamines were stopped 1 month 
and 1 week prior to investigation respectively.
Study design
This is a monocentric cross sectional study. 
Respiratory polygraphy - Apnea-hypopnea index (AHI) 
All patients underwent a standard respiratory polygraphic re-
cording during sleep using type 3 portable monitors (Embletta 
or NOX T3, Resmed Norway AS). The following parameters were 
recorded: plethysmography, nasal flow (nasal cannula pres-
sure transducer), SpO
2
, respiratory movements (abdomen and 
thorax), snoring, ECG, pulse, and position (11). Scoring rules were 
recorded accordance to the 2007 American Academy of Sleep 
Medicine manual, defining apnoea’s as a reduction of 90% or 
more of baseline nasal airflow with a reduction of at least 10 
seconds. Hypopneas were defined as a nasal flow reduction of 
30-90% of baseline, lasting at least 10 seconds accompanied by 
an oxygen desaturation of >4 %.  Diagnosis and severity of OSA 
was graded based on apnea-hypopnea index (AHI); as no OSA 
(<5), mild (5-14.9), moderate (15.0-29.9) or severe (>30.0) (12). 
Peak nasal inspiratory flow (PNIF) 
PNIF is a portable flow meter to assess nasal resistance and gives 
a direct measure of nasal obstruction. Youlten Peak Flow meter 
consists of a face mask which the patients applies over the nose 
with the mouth closed and measures the peak nasal flow of air 
during forced inspiration. The results of three maximal inspira-
tions were recorded and the mean of these results are taken as 
the PNIF (13).
Acoustic rhinometry (AR)
AR is based on reflection of sound waves transmitted into the 
nasal cavity and are reflected back to create a cross-sectional 
map of areas of nasal obstruction as a function of the distance 
from the nostrils. Nasal geometry and volume for various regi-
ons in the nose is measured and we can identify the narrowest 
part of the nasal cavity or minimal cross-section area (MCA) 
(14,15). An impulse acoustic rhinometer [RhinoMetrics SRE2100 
(Rhinoscan version 2.5, built 3.2.5.0)] was handled by 3 trained 
operators. Procedures were in accordance with published proto-
Figure 1. NOSE-VAS scores dependent on AHI scores below versus above 
15. Shown are mean ± 95% confidence interval of NOSE-VAS scores with 
the following order from left to right: 1. Nasal secretion, 2. headache, 
3. pain, 4. sinusitis, 5. coughing, 6. sneezing, 7. general condition and 
8. decreased sense of smell. No significant difference was detected 
dependent on group allocation.
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cols, with the mean of 3 consecutive measurements of volumes 
and minimal cross sectional areas in each nasal cavity, before 
and after decongestion with oxymetazoline (16).  
Nose symptoms on Visual analogue scales (Nose-VAS)
Nose-VAS was used to quantify the subjective feeling of nasal 
obstruction and other sino-nasal related symptoms. Patients 
were asked to put a mark on a 100 mm. linear scale ranging from 
no obstruction/no symptoms to complete obstruction/most-
intense symptoms possible. In the present study we include 
the following 9 symptoms; Nasal obstruction, nasal secretion, 
headache, mid-facial pain, coughing, sneezing, sense of smell, 
complains with sinusitis as well as general health (17,18).
Epworth sleepiness scale psychometry (EpSS)
EpSS is a simple and rapid method for measuring degree of 
daytime sleepiness. EpSS is a patient reported measure of slee-
piness (19). It presents eight different situations about sleepiness 
that are commonly met in daily life. A higher total score (range 
0-24) indicates increased degree of sleepiness (20).  The employed 
EpSS cut-off score separating those with normal versus exces-
sive level of daytime sleepiness is 11 (21).
Statistics
We used a commercially available statistical program package 
(IBM Corp. Released 2012. IBM SPSS Statistics for Windows, 
Version 24.0 Armonk, NY, USA). Figures are reported as mean 
± standard err of the mean (SEM) or mean ± standard devia-
tion (SD). Statistical significance was considered if p<0.05. All 
P-values reported represent two-sided tests. Cronbach alpha, 
Pearson correlation, Partial correlation, Factor analysis and Stu-
dent t-test were calculated as indicated.
Results
Patient characteristics
Of the 651 included patients 191 (29.3 %) stated to have allergy, 
59 (9.1 %) asthma, 133 (20.4 %) hypertension, 49 (7.5 %) cardiac 
disease and 22 (3.4%) kidney disease. In addition, 339 (52.1 %) 
reported to be on any medication.
Associations between Nose-VAS scores, AR and PNIF and 
AHI levels
Using ANOVA analyses, the nose-VAS scores depended on 
AHI scores, both divided by AHI levels (results not shown) and 
divided by AHI lower or higher than 15 (Figure 1). No significant 
difference between the groups was observed.
Correlation between Nose-VAS scores and ESS/AHI index/
ODI scores
As previously published, a significant correlation was shown 
between the following VAS-nose scores and the EpSS score: 
“Nasal secretion”, “headache”, “coughing”, “sneezing” and “general 
condition”.  Studying the nose-VAS scores, only level of “heada-
che” correlated significantly but inversely with the AHI index (r= 
-0.08; p<0.05). Regarding the ODI scores, none of the VAS-nose 
question responses correlated significantly (Table 1). 
If separating the patients by EpSS score levels, the different no-
se-VAS scores lost significant correlations from present among 
low AHI scoring patients to absent among high AHI scoring 
patients by four steps of AHI levels defining no, mild, moderate 
to serious OSA. This was particularly evident comparing patients 
with no versus serious OSA (Table 2). Regarding the “general 
condition” the response levels were significantly correlated in 
the AHI 0-5 group and the AHI above 30 group (Table 2).
We also studied the correlations between the nose-VAS scores 
Figure 2.  Scatter plots showing NOSE-VAS nasal secretion scores by EpSS scores dependent on AHI scores below versus above 15. Statistics (Pearson 
Correlation): (AHI 0-15): r2 = 0.019; p<0.01. A regression line has also been constructed according to the formula: Y = 23 + 0.74 * x. (AHI >15): not sig-
nificant.
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and the EpSS scores in patients with AHI below and above 15 
(Table 3). Then, correlations between the nose-VAS scores and 
the EpSS scores were as in the analyses when all patients were 
included in the group with AHI scores below 15. On the other 
hand, in the group of patients with AHI above 15 there were no 
such relationships (Table 3)(Figure 2). One exception was noted 
regarding “general condition” which scored significantly at the 
same level in both AHI groups.
A significant correlation was determined between EpSS and the 
AHI index (r=0.14; p<0.001) when including all patients (Table 
1). When studying divided groups based on AHI scores with a 
cutoff point of 15, only among patients with a high AHI score, a 
significant correlation was shown (Table 3). 
In the above-mentioned analyses, the associations between 
levels of “nasal congestion” and the other nose-VAS scores were 
systematically included as positive control analyses in order 
to show that the nose-VAS interaction scores stayed the same 
among all patients. This was indeed the case.
Correlation between EpSS and nose-VAS scores dependent 
on age, gender and present comorbidity
Present comorbidity, in particular asthma, but also allergy, 
cardiac disease and hypertonia were associated with increased 
score on the nose-VAS questions (Table 4). The same was the 
case with positive answers to “whether on any medication”. Par-
tial correlation analyses were subsequently performed between 
the EpSS and nose-VAS scores adjusting in step 1 by age and 
gender of the patient and in step 2 by any additionally reported 
comorbidities (Table 5). It was shown that including informa-
tion about co-morbidities explained some, but not all-common 
variance between the EpSS and the nose-VAS scores. This was 
also valid when splitting the patients in groups with AHI scores 
below or above 15 (Table 5). 
In addition, the “nasal congestion” scores were used as posi-
tive controls in order to exclude changed internal association 
between the nose-VAS scores dependent on AHI score levels. 
The controls performed as expected.
Correlation between acoustic rhinomanometry (AR), peak 
nasal inspiratory flow (PNIF) and nose-VAS measures
Results from AR and PNIF were correlated with EpSS, AHI and 
ODI scores. Including all patients, MCA2 correlated to EpSS 
scores (r=-0.10; p<0.05) (Table 1). If studied by AHI level score 
groups, this association was found only among patients scoring 
AHI below15 (Table 3).
Discussion
In the present paper, we have studied the association between 
self-reported nasal obstruction and self-reported nasal com-
plaints given on VAS, nasal airflow measured by PNIF, nasal 
geometry measured by AR and the sleep parameters AHI and 
ODI in 651 patients with the suspicion of SRBD.  There were no 
Table 1. Pearson correlation coefficients between Epworth sleeping scale (EpSS), Apnoe Hypanoe Index (AHI), Oxygen desaturation Index (ODI), gen-
der, age, rhinometry, and NOSE-VAS scores.
* = P<0.05, ** = P<0.01, ***=P<0.001; MCA: nasal cavity Minimal Cross-section Area; PNIF: Peak nasal inspiratory flow.
EpSS AHI  ODI Gender Age BMI
AHI .14***
ODI .19*** .90***
Gender (0= female). -.05 .09* .09*
Age -.01 .18*** .18*** -.06
BMI .14** .30*** .37*** -.06 .05
Nasal congestion .03 -.04 -.01 .05 -.17*** .03
Nasal secretion .10* -.04 -.03 .02 .04 -.04
Headache .12** -.08* .02 -.18*** -.09* .08*
Mid-facial pain .04 -.06 -.04 -.08* -.03 .06
Sinusitis .02 -.08 .05 -.06 -.06 .06
Coughing  .09* -.01 .02 -.02 .00 .06
Sneezing  .09* -.08 -.03 .00 .00 .05
Decr. sense of smell .07 -.04 -.00 .11** -.13** -.04
Decr. gen. condition .15*** .01 .04 -0.6 .05 .11**
MCA1 .02 -.02 -.00 .08* .01 .03
MCA2 -.10* .02 -.02 -.02 -.01 -.00
PNIF -.05 -.06 -.05 .01 -.03 .05
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general significant associations between the nasal parameters 
on one the hand and AHI/ODI levels on the other.
Previous investigations on this are not conclusive. Some investi-
gators have employed the sino-nasal-outcome-test (SNOT-20) to 
explore the issue and claimed that patients suffering from OSA 
have a reduced sino-nasal-quality of life compared to controls 
(22, 23). SNOT-20 is a validated, self-administered quality of life 
instrument specific for symptoms of rhinosinusitis and sensitive 
to clinical changes. It describes the health burden of rhinosi-
nusitis by measuring physical problems, functional limitations 
and emotional consequences of CRS by asking the participants 
to score 20 core symptoms. Few of the above mentioned SNOT 
versus OSA studies have employed ideal control groups, i.e. con-
trol and experimental groups closely related to each other. We 
Table 2. Pearson correlations between NOSE-VAS scores and Epworth sleepiness scores (EpSS) with «nasal congestion» scores as “positive” control; 
divided by AHI score level groups.
* = P<0.05, ** = P<0.01, ***=P<0.001; MCA: nasal cavity Minimal Cross-section Area; PNIF: Peak nasal inspiratory flow; “Nasal congestion” scores as 
positive control.
NOSE-VAS questions about:









Nasal congestion .06 -.06 .09 .03
Nasal secretion .22*** .25*** .02 .26** .13 .07 -.05 .31***
Headache .13* .02 .30** .24** -.00 .08 .09 .18*
Mid-facial pain .05 .12 .12 .24** .06 .13 -.07 -.05
Sinusitis .08 .22*** .04 .24** .03 .26** -.13 .13
Coughing .05 .30*** .13 .14 .20* .17 .01 .35***
Sneezing .13* .21*** -.02 .06 .22* .24** .01 .20*
Decreased sense of smell .12* .37*** .00 .21* .12 .35*** .02 .41***
Decreased general condition .12 .16** .17 .14 .18 .11 .16 .23*
No. respondents in group 260 267 122 131 113 128 117 123
Table 3. Pearson correlation coefficients between Epworth sleepiness scale (EpSS)/AHI/”nasal congestion” score  and VAS-Nose scores with groups by 
low versus high AHI score.
AHI 0-5 AHI 16-
EpSS AHI ODI Nasal 
congestion
EpSS AHI ODI Nasal 
congestion
AHI -.03 .675*** .22** .806***
ODI .12*
Nasal congestion .04   -.13** -.08 .03 -.03 .04
Nasal secretion .14** -.00 .02 .21*** -.00 -.02 -.03 .30***
Headache .15** -.02 .02 .08 .08 -.13 -.02 .19*
Mid-facial pain .08 -.07 .00 .15** -.04 -.05 -.01 .03
Sinusitis .06 -.04 -.02 .24*** -.07 -.14 -.06 .15
Coughing .10* -.04 .02 .25*** .04 -.05 .02 .28***
Sneezing .12* -.10* -.10 .20*** .02 -.03 -.08 .15
Decreased sense of smell .10* -.05 .01 .35*** .01 -.02 .05 .31***
Decr. gen. condition .15** .03 .08 .16*** .15 -.00 .03 .15
MCA1 -.05 -.07 -.02 -.10* .11 .00 .00 -.01
MCA2 -.10* .05 -.11* -.15** -.09 .06 -.04 -.12
PNIF -.07 -.03 -.06 -.12* -.00 -.00 -.06 -.27**
* = P<0.05, ** = P<0.01, ***=P<0.001. “Nasal congestion” scores as positive control.
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therefore hypothesize that previously published differences may 
be secondary to the choices of non-parallel groups. As being an 
important clinical matter, this question needs more scrutiny. We 
have presently studied our cohort by ANOVA analyses studying 
the nose-VAS score results dependent on AHI scores, both divi-
ded by AHI levels and divided by AHI lower or higher than 15. 
No significant differences between the groups were observed. 
The same was the case studying AR and PNIF results. This argues 
strongly against an association between AHI levels on one side 
and nose-VAS, nasal volumes or nasal function on the other.
A hypothesized general association between AHI/ODI and 
nose-VAS/AR scores implies that such associations should be 
demonstrated at individual levels, i.e. with significant cor-
relations between these parameters. Presently, this is not the 
case.  We have, however, previously demonstrated a significant 
correlation between EpSS scores and nasal symptom levels (24). 
In the present investigation, we have extended this to study if 
these associations were present to the same extent in the sub-
groups with and without OSA respectively. We found that the 
association between EpSS score and the NOSE-VAS questions 
primarily was present among the patients with AHI scores below 
15, i.e. patients with not more than mild OSA. These results were 
independent of age, gender, allergy, asthma, cardiac disease & 
hypertonia & kidney disease, any medication, pack-years smo-
king, and BMI. The results also gave support to state that these 
associations decrease stepwise as the AHI score increases.  One 
notable exception was the question about “general condition”. 
It is possible that this association is coincidental as reduced 
Table 4. Pearson correlations between Nose-VAS scores and reported comorbidity.
Nose-VAS questions about: Allergy Asthma Cardiac disease Hypertonia Any medication
Asthma .30***
Cardiac disease .02 .15***
Hypertonia .06 .11** .18***
Any medication .18*** .19*** .15*** .35***
Nasal congestion .13*** .13** -.01 -.01 .015
Nasal secretion .12** .13** .13** .07 .08*
Headache .07 .12** .03 .08 .13**
Mid-facial pain .16*** .19*** .11** .09* .12**
Sinusitis .18*** .16*** .09* .03 .12**
Coughing .04 .17*** .09* .05 .10*
Sneezing .05 .09* .09* .03 .02
Decreased sense of smell .07 .08* .05 .05 -.01
Decreased general condition .07 .13** .09* .11** .21***
Table 5. Partial correlations scores between None-VAS scores and Epworth sleepiness scores (EpSS) including indicated control variables.
Control variables:
Age, gender Age, gender, allergy, asthma, cardiac disease & 
hypertonia & kidney disease, any medication, pack-
years smoking, BMI













Nasal congestion .01 .08 .01 .08
Nasal secretion .15** .27*** .04 .21** .15** .27*** .04 .21**
Headache .22*** .11* .06 .09 .22*** .11* .06 .09
Mid-facial pain .09 .18*** .00 .02 .09 .18*** .00 .02
Sinusitis .08 .24*** -.07  .16* .08 .24*** -.07  .16*
Coughing .09 .26*** .11    .23*** .09 .26*** .11    .23***
Sneezing .09 .18*** .12    .26*** .09 .18*** .12    .26***
Decreased sense of smell .09 .31*** .06    .37*** .09 .31*** .06    .37***
Decreased general condition .15** .17** .19**   .19** .15** .17** .19**   .19**
«Nasal congestion» scores as “positive” control.
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“general condition” may in part also be caused by increased 
daytime sleepiness. This should be investigated in future studies. 
The level of “headache” correlated significantly, but inversely 
with the AHI index, i.e. patients with OSA suffered less from 
headache than those without. This is in contrast to previous 
investigations. The term “sleep apnea headache (SAH)” refers to 
a condition characterized by morning headache with age, male 
gender and BMI as predisposing factors (25, 26). Oxygen desatu-
ration cannot explain the patho¬physiology of SAH alone, and 
CPAP treatment does not seem to improve this headache (27, 28). 
This, combined with our results, questions the overall legitimacy 
of the term. 
There are studies concluding with nasal obstruction as an 
independent risk factor for OSA. Virkkula et al. found that nasal 
resistance in non-obese individuals was related to sleep parame-
ters (29). A link between nasal geometry and OSA has also been 
described by others. 
MCA 1 and MCA 2 were significantly smaller in OSA patients 
compared to controls, and the severity of the sleep disorder was 
inversely correlated to the nasal dimensions. Inconsistently, we 
found a weak, and probably coincidental, association between 
mild OSA (AHI < 15) and MCA 2, i.e. a reduced minimal cross sec-
tional area between 3 and 5, 2 cm. from the nasal orifice, compa-
red to individuals with more serious OSA. This corresponds with 
the dominating opinions about nasal airway morphology and 
OSA: There are no associations. 
With negative results, as in the present study, and results incon-
sistent with previous investigations, it is important to consider 
the validity of the studied parameters. We have included more 
than six hundred patients giving statistical power even to 
negative conclusions. The matter of skewed questionnaire res-
ponse patterns from healthy to OSA patients was addressed by 
studying comparison to other questions. We have systematically 
used the question about “nasal congestion” as a positive control. 
As can be seen from the results, a generally skewed response 
pattern dependent on AHI can probably be ruled out. We have 
also shown expected association between present asthma, al-
lergy and cardiac disease and level of nasal symptoms. 
Regarding the AHI, we have shown a close correlation between 
the AHI and ODI scores as expected. Thus, these two physiolo-
gically different measurements, if presently wrongly measured, 
must be affected similarly. In addition, we have determined an 
association between AHI/ODI on the one side and BMI, gender 
and age of the patient on the other side as expected. Still, a bet-
ter quality than presently used may always be achievable as to 
include parameters.
The present investigation cannot once and for all completely 
rule out all questions about associations between nasal function 
and OSA. Several findings still argue in favor of this association. 
From a nose-anatomical point of view, nasal obstruction during 
sleep may contribute to SRBD because nasal breathing is more 
effective than oral breathing, especially during sleep. Supine 
position may increase nasal resistance through postural reflex 
mechanisms, and changes in hydrostatic pressure in venous 
sinusoids (30). Nasal obstruction has also been related to sleep 
apnea and frequent arousals through upper airway collapse due 
to more negative oropharyngeal pressure during inspiration(31). 
From a neuromuscular point of view, there are speculations 
about decreased sensitivity on nasal mechanoreceptors, particu-
larly prevalent around the nasal vestibule, in OSA-patients (32). 
They are essential in reflex mechanisms against negative pres-
sure in the upper airways through modulation of the genioglos-
sus muscle activity. Their dysfunctionality may represent a link 
between the nose and SRBD. From a respiratory point of view, a 
patent airway depends on a balance between dilating and col-
lapsing forces. The nasal cavity as such is a non-collapsible tube 
as described in the Starling resistor model. However, due to the 
mucosal lining, particularly the part covering the inferior turbi-
nates, it is an active tube responsive to temperature, humidity, 
pollution, emotions, posture, etc. Thus, the narrowest point in 
the nose may change in position and narrowness. Consequently, 
there will be changes in airflow and stimulation of mechanore-
ceptors. This may eventually modulate the collapsible part of the 
airway, the pharynx, and induce SRDB. Furthermore, nasal disor-
ders like polyps, septal deviations etc. causes mouth breathing. 
When this happens, the jaw and tongue move backwards and 
downwards predisposing for airway collapse. Accordingly, there 
are several mechanisms linking the nose to sleep. However, 
a most important matter that remains to be understood and 
explained is why nasal characteristics do not appear to be as-
sociated with the most serious form of SRBD, namely OSA. That 
this really is the case has been confirmed in a number of inter-
ventional studies looking at the effect of medical and surgical 
measures to open the nose on OSA. There is not sufficient data 
to recommend drug treatment of OSA. Nasal surgery does not 
appear to be able to reduce OSA severity. Neither does nasal 
dilators (32). 
Conclusions
Based on more than 650 patients, we conclude that there is 
no general association between nose patency and AHI or ODI 
scores. Thus, the claim about a causal relationship between the 
nose function and OSA has been further weakened. Medical 
and surgical measures against nasal obstruction are not likely to 
improve the sleep disorder. Nevertheless, treating nose disease 
may improve daytime sleepiness, as well as improve adherence 
to CPAP in its own right.
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